Stevens S L, Stenzel-Poore M P
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, 3181 Sam Jackson Park Road, Portland, OR, USA.
Biochem Soc Trans. 2006 Dec;34(Pt 6):1352-5. doi: 10.1042/BST0341352.
Ischaemic tolerance in the brain is a powerful adaptive defence that involves an endogenous programme of neuroprotection culminating in marked protection against brain injury from ischaemia. A range of preconditioning stimuli exist that differ in ligand and target characteristics but share the common feature of causing mild stress or insult without inducing overt injury. The protective phenotype that emerges confers tolerance to subsequent exposure to injurious insults. Tolerance to injury is the result of genomic reprogramming, an adaptation comprising regulatory processes that countermand injurious effectors and invoke novel neuroprotective pathways. TLRs (Toll-like receptors) play important roles in sensing potential danger/insult in the form of pathogens as well as endogenous stress molecules that occur in response to mild injury (e.g. heat-shock proteins). Recent studies suggest that TLRs are novel and potent preconditioning targets that offer substantial promise to protect the brain from ischaemic injury.
脑缺血耐受是一种强大的适应性防御机制,它涉及一个内源性神经保护程序,最终对缺血性脑损伤产生显著保护作用。存在一系列预处理刺激,它们在配体和靶点特征方面有所不同,但具有共同特征,即引起轻度应激或损伤而不诱发明显损伤。所出现的保护性表型赋予对随后暴露于有害损伤的耐受性。对损伤的耐受性是基因组重编程的结果,这是一种适应性变化,包括对抗有害效应器并激活新的神经保护途径的调节过程。Toll样受体(TLRs)在感知病原体形式的潜在危险/损伤以及响应轻度损伤而出现的内源性应激分子(如热休克蛋白)方面发挥重要作用。最近的研究表明,TLRs是新的强效预处理靶点,有望为保护大脑免受缺血性损伤提供实质性帮助。